Search Results - "Lodygin, Dimitri"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Functional epigenomics identifies genes frequently silenced in prostate cancer by LODYGIN, Dimitri, EPANCHINTSEV, Alexey, MENSSEN, Antje, DIEBOLD, Joachim, HERMEKING, Heiko

    Published in Cancer research (Chicago, Ill.) (15-05-2005)
    “…In many cases, silencing of gene expression by CpG methylation is causally involved in carcinogenesis. Furthermore, cancer-specific CpG methylation may serve…”
    Get full text
    Journal Article
  2. 2

    Prostate cancer is characterized by epigenetic silencing of 14-3-3σ expression by LODYGIN, Dimitri, DIEBOLD, Joachim, HERMEKING, Heiko

    Published in Oncogene (02-12-2004)
    “…In order to identify tumor suppressive genes silenced by CpG methylation in prostate carcinoma (PCa), we determined genome-wide expression changes after…”
    Get full text
    Journal Article
  3. 3

    Induction of the Cdk inhibitor p21 by LY83583 inhibits tumor cell proliferation in a p53-independent manner by Lodygin, Dimitri, Menssen, Antje, Hermeking, Heiko

    Published in The Journal of clinical investigation (01-12-2002)
    “…Using microarray analysis, we have detected downregulation of several components of the cGMP signaling pathway during replicative senescence of primary human…”
    Get full text
    Journal Article
  4. 4

    DNA stool test for colorectal cancer : Hypermethylation of the secreted frizzled-related protein-1 gene by WEI ZHANG, BAUER, Michael, CRONER, Roland S, PELZ, Jorg O. W, LODYGIN, Dimitri, HERMEKING, Heiko, STÜRZL, Michael, HOHENBERGER, Werner, MATZEL, Klaus E, POTTER, Mark A

    Published in Diseases of the colon & rectum (01-10-2007)
    “…To investigate a potential mode of noninvasive screening for colorectal cancer, we evaluated the hypermethylation of the secreted frizzled-related protein-1…”
    Get full text
    Journal Article
  5. 5

    Analysis of 14-3-3σ expression in hyperproliferative skin diseases reveals selective loss associated with CpG-methylation in basal cell carcinoma by LODYGIN, Dimitri, YAZDI, Amir S, SANDER, Christian A, HERZINGER, Thomas, HERMEKING, Heiko

    Published in Oncogene (21-08-2003)
    “…The p53-regulated 14-3-3σ gene encodes an inhibitor of cell cycle progression essential for senescence and clonal evolution of keratinocytes in vitro. Here we…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Downregulation of 14-3-3σ in ovary, prostate and endometrial carcinomas is associated with CpG island methylation by Mhawech, Paulette, Benz, Ana, Cerato, Christelle, Greloz, Vincent, Assaly, Mounia, Desmond, Julian C, Koeffler, H Phillip, Lodygin, Dimitri, Hermeking, Heiko, Herrmann, François, Schwaller, Juerg

    Published in Modern pathology (01-03-2005)
    “…The 14-3-3σ inhibitor of cell cycle progression has been shown to be target of epigenetic deregulation in many forms of human cancers; however, its role in…”
    Get full text
    Journal Article
  8. 8

    Prostate cancer is characterized by epigenetic silencing of 14-3-3sigma expression by Lodygin, Dimitri, Diebold, Joachim, Hermeking, Heiko

    Published in Oncogene (02-12-2004)
    “…In order to identify tumor suppressive genes silenced by CpG methylation in prostate carcinoma (PCa), we determined genome-wide expression changes after…”
    Get full text
    Journal Article
  9. 9

    Prostate cancer is characterized by epigenetic silencing of 14-3-3p[sigma] expression by Lodygin, Dimitri, Diebold, Joachim, Hermeking, Heiko

    Published in Oncogene (02-12-2004)
    “…In order to identify tumor suppressive genes silenced by CpG methylation in prostate carcinoma (PCa), we determined genome-wide expression changes after…”
    Get full text
    Journal Article
  10. 10

    Induction of the Cdk inhibitor p21 by LY83583 inhibits tumor cell proliferation in a p53-independent manner by Lodygin, Dimitri, Menssen, Antje, Hermeking, Heiko

    Published in The Journal of clinical investigation (01-12-2002)
    “…Using microarray analysis, we have detected downregulation of several components of the cGMP signaling pathway during replicative senescence of primary human…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Analysis of 14-3-3 expression in hyperproliferative skin diseases reveals selective loss associated with CpG-methylation in basal cell carcinoma by Lodygin, Dimitri, Yazdi, Amir S, Sander, Christian A, Herzinger, Thomas, Hermeking, Heiko

    Published in Oncogene (21-08-2003)
    “…The p53-regulated 14-3-3sigma gene encodes an inhibitor of cell cycle progression essential for senescence and clonal evolution of keratinocytes in vitro. Here…”
    Get full text
    Journal Article
  13. 13

    Analysis of 14-3-3sigma expression in hyperproliferative skin diseases reveals selective loss associated with CpG-methylation in basal cell carcinoma by Lodygin, Dimitri, Yazdi, Amir S, Sander, Christian A, Herzinger, Thomas, Hermeking, Heiko

    Published in Oncogene (21-08-2003)
    “…The p53-regulated 14-3-3sigma gene encodes an inhibitor of cell cycle progression essential for senescence and clonal evolution of keratinocytes in vitro. Here…”
    Get full text
    Journal Article
  14. 14

    Downregulation of 14-3-3 in ovary, prostate and endometrial carcinomas is associated with CpG island methylation by Mhawech, Paulette, Benz, Ana, Cerato, Christelle, Greloz, Vincent, Assaly, Mounia, Desmond, Julian C, Koeffler, H Phillip, Lodygin, Dimitri, Hermeking, Heiko, Herrmann, François, Schwaller, Juerg

    Published in Modern pathology (01-03-2005)
    “…The 14-3-3sigma inhibitor of cell cycle progression has been shown to be target of epigenetic deregulation in many forms of human cancers; however, its role in…”
    Get full text
    Journal Article
  15. 15

    Downregulation of 14-3-3sigma in ovary, prostate and endometrial carcinomas is associated with CpG island methylation by Mhawech, Paulette, Benz, Ana, Cerato, Christelle, Greloz, Vincent, Assaly, Mounia, Desmond, Julian C, Koeffler, H Phillip, Lodygin, Dimitri, Hermeking, Heiko, Herrmann, François, Schwaller, Juerg

    Published in Modern pathology (01-03-2005)
    “…The 14-3-3sigma inhibitor of cell cycle progression has been shown to be target of epigenetic deregulation in many forms of human cancers; however, its role in…”
    Get full text
    Journal Article